Andrew Craig earned his BSc in Biochemistry at Queen’s University (1993) prior to completing his PhD in the field of post-transcriptional regulation of gene expression in Dr Nahum Sonenberg’s lab at McGill University (PhD 1998). PDF training in cancer biology and transgenic mouse models was performed with Dr Peter Greer at Queen's Cancer Research Labs (1998-2002) prior to starting his own lab in the Department of Biochemistry at Queen's (since 2002). Dr Craig has received numerous research awards including Canadian Institutes of Health Research New Investigator award (2004-9) and the 2011 Young Investigator award from the Canadian Cancer Society.
The Craig lab studies tyrosine kinase signaling pathways that regulate cell motility, tissue invasion and inflammation. Current projects focus on mast cells, inflammation, chronic diseases, and tumour progression. The lab also studies F-BAR proteins and microRNAs that are altered in metastatic cancer models using both cell culture and mouse models.